AHNS43
EVOLVING BEYOND THE "UNKNOWN PRIMARY": TRANSORAL SURGERY FACILITATES ROUTINE IDENTIFICATION OF A T1-MICROSCOPIC P16+ OROPHARYNGEAL SCC
Oropharynx / HPV Related Disease
F. Christopher Holsinger, Professor Head and Neck Surgery1; Michael C Topf, Assistant Professor OHNS2; Ryan K Orosco, Assistant Professor OHNS3; Andrew C Birkland, Assistant Professor OHNS4; Nikita Bedi, Clinical Research Coordinator1; A. Dimitrios Colevas, Professor Medical Oncology1; Beth M Beadle, Professor Radiation Oncology1
1Stanford University; 2Vanderbilt University; 3University of California at San Diego; 4University of California at Davis
AHNS44
THE COST IMPLICATIONS OF A PROPOSED MODIFIED SURVEILLANCE STRATEGY TO DETECT DISEASE RECURRENCE IN HPV+ OROPHARYNGEAL CARCINOMA UTILIZING PLASMA CIRCULATING TUMOR HPV DNA: A SINGLE INSTITUTION'S EXPERIENCE.
Michael Lin1; Alexander Zhu, MD2; Katherine L Fedder, MD3; Mark J Jameson, MD, PhD, FACS3; Paul Read, MD, PhD2; Christopher McLaughlin, MD2; Jonathan C Garneau, MD3
1UVA School of Medicine; 2UVA Radiation Oncology; 3UVA Otolaryngology
AHNS45
VIRTUAL SURGICAL PLANNING FOR MAXILLARY RECONSTRUCTION WITH THE SCAPULAR FREE FLAP: AN EVALUATION OF A SIMPLE CUTTING GUIDE DESIGN
Reconstruction / Microvascular Surgery
Khanh Linh Tran; Jae Young Kwon; Xi Yao Gui; James Scott Durham, MD; Eitan Prisman, MD, MA
Division of Otolaryngology, Department of Surgery, Faculty of Medicine, University of British Columbia
AHNS46
PATTERN OF LYMPH NODE METASTASIS OF CUTANEOUS MALIGNANCIES INVOLVING THE TEMPORAL BONE
Skin Cancer
Justin M Hintze, MD; Holly Jones, MD; Adrien Gendre, MD; Rory McConn Walsh, MD; Neville Shine, MD; James Paul O'Neill, MD
Beaumont Hospital, Dublin, Ireland
AHNS47
THE EFFECTS OF PSYCHOSOCIAL DETERMINANTS ON POSTOPERATIVE COMPLICATIONS OF HEAD AND NECK FREE FLAP PATIENTS
Liyang Tang, MD; Carlos X Castellanos, MS; Daniel Kwon, MD; Niels Kokot, MD
Keck Medicine of USC
AHNS49
CUTANEOUS HEAD & NECK MALIGNANCIES WITH LOW AND HIGH-RISK PERINEURAL INVASION: PATTERNS OF TREATMENT FAILURE & ONCOLOGIC OUTCOMES
Theodore A Gobillot, PhD1; Matthew Greer, MD2; Upendra Parvathaneni, MD2; Zain H Rizvi, MD1
1Dept. of Otolaryngology-Head & Neck Surgery, University of Washington; 2Dept. of Radiation-Oncology, University of Washington
AHNS50
IMPACT OF IMMUNOTHERAPY FOR HEAD AND NECK CANCER ON END-OF-LIFE CARE UTILIZATION AND COSTS
Education / Care Delivery
William J Benjamin, MPH1; Pratyusha Yalamanchi, MD, MPH1; Steven B Chinn, MD, MPH1; Michelle M Chen, MD, MHS2
1Department of Otolaryngology - Head and Neck Surgery, University of Michigan; 2Department of Otolaryngology - Head and Neck Surgery, Cedars Sinai Medical Center
AHNS Annual Meeting
Held during the Combined Otolaryngology
Spring Meetings (COSM)
April 27-28, 2022
Hyatt Regency Dallas
Dallas, TX